CareDx, Inc. (CDNA): Depreciation & Amortization
$15.02M
Year ended 2025-12-31
$14.41M
Trailing 12 months to 2026-06-30
+9.0%
3-year compound annual growth
+16.5%
5-year compound annual growth
+34.1%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.02M | +5.8% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $14.19M | -1.3% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $14.39M | +24.1% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $11.60M | +31.8% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $8.80M | +25.6% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $7.01M | +26.9% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $5.52M | +31.0% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $4.21M | +13.1% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $3.73M | +27.6% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $2.92M | +266.8% | 2017-04-21, From 2016-01-01 |
| 2015-12-31 | $796.0K | +55.5% | 2017-04-21, From 2015-01-01 |
| 2014-12-31 | $512.0K | -22.8% | 2017-04-21, From 2014-01-01 |
| 2013-12-31 | $663.0K | -38.2% | 2016-03-29, From 2013-01-01 |
| 2012-12-31 | $1.07M | n/a | 2015-03-31, From 2012-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| CareDx, Inc. (CDNA) | 2025-12-31 | $15.02M | +5.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $40.77M | +154.9% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $24.12M | -3.2% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $6.90M | -1.4% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $21.41M | -8.7% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $22.61M | -53.8% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $39.74M | -6.3% |
| Biodesix Inc (BDSX) | 2025-12-31 | $5.67M | -1.8% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $136.10M | +8.6% |
Compare CDNA, CSTL, FLGT, BLLN side by side · Screen every company in Services-Medical Laboratories ↗